Squamous Cell Carcinoma of the Head and Neck
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Head and Neck.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-03-02Clinical Trial Update: A Study to Evaluate MRG003 vs Cetuximab/Methotrexate in in the Treatment of Patients With RM-SCCHN [Phase 3]
Phase 3 trial comparing MRG003 to Cetuximab/Methotrexate in recurrent/metastatic squamous cell carcinoma of the head and neck is ongoing wit…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Tolerance and Efficacy of Pembrolizumab or Cetuximab Combined With RT in Patients With Locally Advanced HNSCC [Phase 2]
Phase 2 trial investigating tolerance and efficacy of pembrolizumab or cetuximab with radiotherapy in locally advanced head and neck squamou…
-
CLINICAL_TRIALS trial_result · 2023-02-28Clinical Trial Update: Arginase-1 Peptide Vaccine in Patients With Metastatic Solid Tumors [Phase 1]
Phase 1 trial update on an arginase-1 peptide vaccine in patients with metastatic solid tumors, including non-small cell lung cancer and uro…
-
CLINICAL_TRIALS trial_result · 2023-01-18Clinical Trial Update: Nivolumab in Recurrent and/or Metastatic SCCHN [Phase 2]
Phase 2 trial update for nivolumab in recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) that is platinum-refractory,…
-
CLINICAL_TRIALS trial_result · 2022-12-30Clinical Trial Update: Addition of SNS-301 to Checkpoint Inhibitor Treatment in Metastatic/Recurrent SCCHN [Phase 1, Phase 2]
Clinical trial investigating SNS-301 in combination with checkpoint inhibitors for metastatic/recurrent squamous cell carcinoma of the head …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-11-18Clinical Trial Update: A Randomized Phase II Study on the Optimization of Immunotherapy in Squamous Carcinoma of the Head and Neck [Phase 2]
A randomized Phase II trial evaluating optimization of immunotherapy in recurrent or metastatic squamous cell carcinoma of the head and neck…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Panitumumab-IRDye800 Compared to Sentinel Node Biopsy and (Selective) Neck Dissection in Identifying Metastatic Lymph Nodes in Patients With Head&Neck Cancer [Phase 2]
Phase 2 trial comparing panitumumab-IRDye800 imaging against sentinel node biopsy and selective neck dissection for identifying metastatic l…
-
CLINICAL_TRIALS trial_result · 2022-06-16Clinical Trial Update: Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN [Phase 2]
Phase 2 trial evaluating neoadjuvant nivolumab and lirilumab, followed by surgery and adjuvant nivolumab and lirilumab for squamous cell car…
-
CLINICAL_TRIALS trial_result · 2022-04-21Clinical Trial Update: Study of Nivolumab in Combination With Ipilimumab Versus Nivolumab in Combination With Ipilimumab Placebo in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating nivolumab plus ipilimumab versus nivolumab plus ipilimumab placebo in recurrent or metastatic squamous cell carcino…
-
CLINICAL_TRIALS trial_result · 2022-03-11Clinical Trial Update: Comparison of Two Concomitant Administration of RT With Cisplatin in Standard Infusion or Fractional Infusion [Phase 2]
Phase 2 trial comparing two concomitant administration methods of radiotherapy with cisplatin in standard vs fractional infusion for squamou…
-
CLINICAL_TRIALS trial_result · 2022-02-14Clinical Trial Update: Re-irradiation With Fractionated Stereotactic Radiosurgery Plus Cetuximab in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 trial evaluating re-irradiation with fractionated stereotactic radiosurgery plus cetuximab in patients with recurrent squamous cell …
-
CLINICAL_TRIALS trial_result · 2021-12-29Clinical Trial Update: Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors [Phase 1, Phase 2]
Phase 1/2 safety study of tisotumab vedotin (HuMax®-TF-ADC) in patients with solid tumors completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-11-23Clinical Trial Update: Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & Neck [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports results for durvalumab (MEDI4736) in combination with AZD9150 or AZD5069 in patients with advanced…
-
CLINICAL_TRIALS trial_result · 2021-11-04Clinical Trial Update: Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. [Phase 2]
Phase 2 clinical trial update on tisotumab vedotin with continued treatment in patients with various solid tumors, including gynecologic and…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: SHR-1701 in Patients With Recurrent/Metastatic Scchn [Phase 2]
Phase 2 clinical trial update for SHR-1701 in recurrent/metastatic squamous cell carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2021-10-14Clinical Trial Update: Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Clinical trial update for avelumab in combination with bempegaldesleukin with or without talazoparib or enzalutamide in advanced solid tumor…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer [Phase 3]
Phase 3 trial evaluating nivolumab alone or with cisplatin plus radiotherapy in cisplatin-eligible or -ineligible locally advanced squamous …
-
CLINICAL_TRIALS trial_result · 2021-06-11Clinical Trial Update: PD 0332991 and Cetuximab in Patients With Incurable SCCHN [Phase 1, Phase 2]
Phase 1/2 trial investigating PD-0332991 (palbociclib) with cetuximab in patients with incurable squamous cell carcinoma of the head and nec…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Navigation for Timely Adjuvant Therapy for Patients With Locally Advanced HNSCC [NA]
Clinical trial update on timely adjuvant therapy for locally advanced head and neck squamous cell carcinoma; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-12Clinical Trial Update: A Study of the Combination of Cetuximab and Methotrexate in Recurrent or Metastatic Cancer of the Head and Neck [Phase 1, Phase 2]
Clinical trial update for a Cetuximab and Methotrexate combination in squamous cell carcinoma of the head and neck (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2021-03-02Clinical Trial Update: Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC) [Phase 2]
Phase 2 clinical trial evaluating nab-paclitaxel with cisplatin vs nab-paclitaxel alone as induction therapy for locally advanced squamous c…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) [Phase 3]
Phase 3 trial comparing avelumab plus standard chemoradiotherapy versus chemoradiotherapy alone in locally advanced head and neck squamous c…
-
CLINICAL_TRIALS trial_result · 2020-12-02Clinical Trial Update: A Study of SBRT for Squamous Cell Carcinoma of the Head and Neck [Phase 2]
Phase 2 clinical trial investigating SBRT for squamous cell carcinoma of the head and neck.
-
CLINICAL_TRIALS trial_result · 2020-10-27Clinical Trial Update: PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluated BKM120 (buparlisib) plus cetuximab for recurrent or metastatic head and neck squamous cell carcinoma; r…
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: The Addition of Pembrolizumab to Postoperative Radiotherapy in Cutaneous Squamous Cell Cancer of the Head and Neck [Phase 2]
Phase 2 trial evaluating adding pembrolizumab to postoperative radiotherapy in cutaneous squamous cell carcinoma of the head and neck; compl…